年会的另一大目标是推进国际化。除了JCA-AACR联合研讨会和国际会议(IS)之外,我们还计划举办特别专题国际研讨会。此外,还将邀请玛嘉烈公主癌症中心的Lillian Siu博士和耶鲁大学的Joseph Schlessinger博士等世界顶级癌症研究人员发表特别演讲。我们希望这些活动能为与会者提供接触国际前沿研究的机会。 最后,本次年会自1969年...
The American Association for Cancer Research (AACR) and Japanese Cancer Association 0CA) continued an established tradition of providing a unique forum for scientific exchange primarily (but not exclusively) among American and Japanese scientists and clinicians interested in cancer biology and treatment ...
Innovative approaches to the prevention, diagnosis, and therapy of cancer: fourth joint conference of the American Association for Cancer Research (AACR) a... Innovative approaches to the prevention, diagnosis, and therapy of cancer: fourth joint conference of the American Association for Cancer ...
信诺维SOS1抑制剂将在第7届JCA-AACR展示 关于XNW22013 XNW22013是EVOPOINT信诺维自主研发的小分子SOS1抑制剂, 可与信诺维自主研发的另一款KRASG12C抑制剂XNW14011联合使用治疗有KRASG12C突变的肿瘤。 临床前实验数据显示XNW22013在体外和体内的药效,安全性,以及吸收、分布、代谢和排泄(ADME) 和药代动力学性质(PK...